Non-invasive method for evaluating the development of interstitial structure and cancer malignancy using contrast-enhanced ultrasonography using Sonazoid

Non-invasive method for evaluating the development of interstitial structure and cancer malignancy using contrast-enhanced ultrasonography using Sonazoid - Non-invasive method for evaluating the development of interstitial structure and cancer malignancy using contrast-enhanced ultrasonography using Sonazoid

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011330

Enrollment

Registered

2013-07-31

Start date

2004-07-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. malignant tumor in the liver 2. chronic liver disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: age; over 20 years Gender: unquestioned Patients with any of the following 1. And or, with malignant tumors, patients with malignant tumor is suspected 2. Chronic liver disease patients with malignant tumors

Exclusion criteria

Exclusion criteria: Patients with a history of hypersensitivity to drug test Patients who are allergic to egg products or egg Patient nursing and pregnancy Patients attending physician has determined is inappropriate participation in this study

Design outcomes

Primary

Measure	Time frame
Effectiveness of Sonazoid contrast ultrasound in the diagnosis and grade definitive diagnosis of malignancy	—

Countries

Japan

Contacts

Public ContactSawako Uchida

Osaka City University Graduate School of Medicine Department of Hepatology

sawako@med.osaka-cu.ac.jp06-6645-3905

Outcome results